The Japanese Society of Hypertension (JSH) published the new JSH guidelines for the management of hypertension in 2014, which is the revision of the JSH guidelines of 2009. The primary objective of the guideline is to provide physicians the standard treatment strategy of hypertension to prevent the hypertension-related target organ damage and cardiovascular events. The management of hypertension should be performed in hypertensive patients with a blood pressure of ≥ 140/90 mm Hg. As Asians have a higher prevalence of stroke than of coronary artery disease and stroke is more steeply associated with the level of blood pressure, the target blood pressure should be lower than 130/80 mm Hg for high-risk patients such as those with diabetes or chronic kidney disease. Because of the increasing prevalence of obesity and the related metabolic syndrome, more salt intake and higher salt sensitivity in the population, lifestyle modifications are necessary in hypertensive patients and subjects with high normal blood pressure. This guideline provides evidence-based recommendations for the management of patients with hypertension with the characteristics of our society.
Introduction
The Japanese Society of Hypertension published the new guidelines 'The Japanese Society of Hypertension (JSH) Guidelines for the Management of Hypertension in 2014' (JSH2014GL), aiming at a more effective prevention of hypertension-related organ damage and cardiovascular events in consideration of Asian characteristics ( fig. 1 ) [1] [2] [3] [4] , which are different from The importance of BP control throughout 24 h including sleep and morning periods was highly stressed in the JSH2014GL [1] as well as in recently published Western and international guidelines [6, 7] , but not in two other guidelines [8, 9] . Both home BP monitoring and ambulatory BP (ABP) monitoring (ABPM) as well as office BP are recommended to use complementarily for the diagnosis of hypertension ( fig. 2 ; table 5 ). Especially home BP monitoring is recommended to be used in clinical practice as the first step. In previous studies, home and ABPs are more closely associated with organ damage and cardiovascular prognosis than office BP in both hypertensive and community-dwelling Asian subjects [10] [11] [12] [13] [14] [15] [16] . (table 1)  C1/2  based on the results at evidence level III, IV, V, or VI  (table 1)  D  There are ≥1 results at evidence level I or II (table 1) Consensus-based recommendation grade is expressed as ʻconsen-susʼ. Based on the discrepancy between the office and out-of office BPs, white coat hypertension and masked hypertension are diagnosed ( fig. 3 ) . Subtypes of masked hypertension are morning hypertension, nocturnal hypertension, and daytime hypertension ( fig. 3 ) . Morning hypertension and morning BP surge [17] [18] [19] [20] [21] [22] [23] [24] as well as nocturnal hypertension and a riser pattern of nocturnal BP dipping [25] [26] [27] [28] [29] [30] were demonstrated to be associated with cardiovascular risk in Asian studies.
Key Points
1. Clinic BP should be measured by maintaining the arm-cuff position at the heart level during rest in a seated position. The measurement must be performed two or more times If necessary, ABPM is performed
Diagnosis of hypertension
Definitive diagnosis of hypertension Diagnosis of white coat hypertension
Diagnosis of masked hypertension *1 When a clinic blood pressure-based diagnosis differs from a home blood pressure-based diagnosis, the latter should be predominantly adopted. The blood pressure obtained by selfmeasurement refers to that measured using an automatic sphygmomanometer located in a public facility or at the workplace/pharmacy. *2 Criteria for hypertension regarding ambulatory blood pressure include a mean 24-hour blood pressure of 130/80 mmHg or more, a mean daytime blood pressure of 135/85 mmHg or more, and a mean nighttime blood pressure of 120/70 mmHg or more. When ambulatory blood pressure monitoring is possible, patients meeting one of the above criteria are regarded as having hypertension or masked hypertension. When all values are below the above criteria, patients are regarded as normal or having white coat hypertension. Indication for ABPM is shown in Table 5 . *3 Although this diagnostic procedure is applicable for untreated hypertensive subjects, it must be considered that masked hypertension is also present in hypertensive individuals receiving treatment. 
Principles of Treatment
The management of hypertension in accordance with the JSH2014GL should be performed in hypertensive patients with a BP of ≥ 140/90 mm Hg. In those with diabetes mellitus and chronic kidney disease (CKD) complicated by proteinuria, in which the risk of stroke, heart disease, and renal failure is high, hypertension treatment must be conducted if BP is ≥ 130/80 mm Hg. On the other hand, in hypertensive patients with metabolic syndrome, lifestyle modifications are necessary even in those with a high-normal BP (130-139/85-89 mm Hg). Even in normotensive patients, the prevention of hypertension through lifestyle modifications such as salt restriction, correction of obesity, and exercise is an important issue as a population strategy.
The most important difference between JSH2014GL and Western guidelines are the different target BP levels for high-risk patients with diabetes and/or CKD. Recently revised Western guidelines increased the target BP levels up to 140/90 mm Hg for these high-risk hypertensive patients [6] [7] [8] [9] . As a characteristic of East Asian patients, the slope of the association between clinic BP level and stroke risk is steeper than that for Western patients [2] [3] [4] . In addition, as the phenotype of cardiovascular disease, stroke occurs more frequently than myocardial infarction [3, 4, 16] . Considering these Asian characteristics, in the JSH2014GL, the target BP levels remained at 130/80 mm Hg for high-risk hypertensive patients with diabetes and/or CKD with proteinuria ( fig. 4 ). In addition, JSH2014GL recommended to achieve a home BP <125/75 mm Hg for hypertensive patients with diabetes ( fig. 4 ) because two studies demonstrated the benefits of patients who could achieve this level [31, 32] . 
Key Points

Lifestyle Modifications
Asian subjects are likely to have a high salt intake with high salt sensitivity [4, 33] . Thus, salt restriction should be more effective in Asian patients than in Western patients. 
Key Points
Treatment with Antihypertensive Drugs
The JSH2014GL again stressed that BP lowering per se is more important than the different classes of antihypertensives. A recent meta-analysis of Asian clinical trials supported this statement [34] . The JSH2014GL separately used the words 'major antihypertensive drugs' and 'first-line drugs' and defined 'first-line drugs' as those that could be used in patients without any compelling indications. The major drugs included beta blockers; however, beta blockers are excluded from the first-line drugs.
Compelling indications are shown in figure 5 . The RAS inhibitor is recommended to be used as the first-line drug for high-risk hypertensive patients with diabetes and/or CKD with albuminuria [35, 36] . The procedures of hypertension treatment in the absence of compelling indications are shown in figure 6 . To achieve a target BP level, the combination of drugs are *1 In elderly patients, administration should be started at 1/2 of the standard dose, and the dose should be increased at 1-to 3-month intervals Ca channel blockers * Combination therapy with an ARB and an ACE inhibitor is not commonly used. If the two drugs are concomitantly used to protect the kidney, they must be carefully administered while monitoring kidney function and considering the risk of hyperkalemia.
Fig. 7.
Combination of two drugs [1] .
